Treatment of Parkinson's disease with controlled-release Carbidopa/L-DOPA.
Pahwa
R
R
Department of Neurology, University of Kansas Medical Center, Kansas City 66160-7314, USA.
Koller
W C
WC
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000978:Antiparkinson Agents / Q000008:administration & dosage* / Q000627:therapeutic use*; D002230:Carbidopa / Q000008:administration & dosage* / Q000627:therapeutic use*; D003692:Delayed-Action Preparations; D004338:Drug Combinations; D005260:Female; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage* / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy*
D000978:Antiparkinson Agents; D003692:Delayed-Action Preparations; D004338:Drug Combinations; D007980:Levodopa; D002230:Carbidopa